Scaling and Root Planning in a Patient Taking Chronic Corticosteroid Therapy for Lupus Erythematosus
The dental provider should be aware of the oral manifestations of systemic lupus erythematosus (SLE). Patients with SLE may be on chronic oral corticosteroids, which can increase the risk for periodontitis and opportunistic oral infections in addition to inducing multiple systemic adverse effects. Disease complications such as lupus nephritis and comorbid antiphospholipid antibody syndrome can further impact dental decision-making including around medications to prescribe or hemostatic measures to employ during treatment. Patients with SLE on systemic corticosteroid therapy usually do not require steroid supplementation before or after non-surgical or surgical dental treatment.
Source: Dental Clinics of North America - Category: Dentistry Authors: Payam Mirfendereski, Rogan Magee, Katherine France Source Type: research
More News: Antiphospholipid Syndrome | Corticosteroid Therapy | Dentistry | France Health | Hughes Syndrome | Lupus | Nephritis